Effect of Lidocaine 1% and 2% in the Tube Cuff on Postoperative Sore Throat and Cough
ELIT
1 other identifier
interventional
150
0 countries
N/A
Brief Summary
Comparing the effect of different methods of endotracheal tube cuff inflation on the occurrence of a postoperative sore throat and cough (Air vs Lidocaine 1% vs Lidocaine 2%).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2018
CompletedStudy Start
First participant enrolled
January 1, 2019
CompletedFirst Posted
Study publicly available on registry
January 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedJanuary 15, 2019
January 1, 2019
3 months
December 22, 2018
January 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Sore throat intensity 0
Throat pain evaluation using the visual analog scale of pain (range from 0 cm (no pain) to 10 cm (very intense pain))
hour 0 after extubation
Sore throat intensity 2
Throat pain evaluation using the visual analog scale of pain (range from 0 cm (no pain) to 10 cm (very intense pain))
at 2 hours after extubation
Sore throat intensity 6
Throat pain evaluation using the visual analog scale of pain (range from 0 cm (no pain) to 10 cm (very intense pain))
at 6 hours after extubation
Sore throat intensity 24
Throat pain evaluation using the visual analog scale of pain (range: from 0 cm (no pain) to 10 cm (very intense pain))
at 24 hours after extubation
Cough intensity 0
Cough intensity evaluation using the visual analog scale of cough (range from 0 cm (no cough) to 10 cm (very severe cough))
hour 0 after extubation
Cough intensity 2
Cough intensity evaluation using the visual analog scale of cough (range from 0 cm (no cough) to 10 cm (very severe cough))
at 2 hours after extubation
Cough intensity 6
Cough intensity evaluation using the visual analog scale of cough (range from 0 cm (no cough) to 10 cm (very severe cough))
at 6 hours after extubation
Cough intensity 24
Cough intensity evaluation using the visual analog scale of cough (range from 0 cm (no cough) to 10 cm (very severe cough))
at 24 hours after extubation
Study Arms (3)
Air
ACTIVE COMPARATOREndotracheal tube cuff inflation with air
Lidocaine 1%
EXPERIMENTALEndotracheal tube cuff inflation with Lidocaine 1%
Lidocaine 2%
EXPERIMENTALEndotracheal tube cuff inflation with Lidocaine 2%
Interventions
The induction of anesthesia will be made following a preoxygenation with a facial mask with 100% Oxygen. It consists on the intravenous injection of Sufentanil 5 mcg or Fentanyl 50mcg, Lidocaine 1mg/Kg, Propofol 2.5mg/kg, Rocuronium 0.6mg/kg or Cisatracurium 0.15mg/kg.
Maintenance of anesthesia will be done by sevoflurane + nitrous oxide, and reinjections of morphinomimetics and curare will be made as needed (the total doses will be noted at the end of the intervention).
The intubation is made by a N° 7.5 tube in men and a N° 7 tube in women. Cuff inflation will be done upon placement of the endotracheal tube. The cuff's pressure will be monitored at several intervals of the intervention and kept \< or = 20 centimeter of water (cmH2O).
All patients will receive Paracetamol every 6 hours for the first 24 hours after the end of surgery.
Eligibility Criteria
You may qualify if:
- Patients over 18 years old
- American Society of Anesthesiologists classification (ASA) category 1 or 2
- High pressure, low volume endotracheal tube - (Lo-pro)
You may not qualify if:
- Ear nose and throat and cranial surgery
- Ear nose and throat pathologies
- Asthma and bronchial hyperreactivity
- Chronic cough
- Diabetes
- Cognitive disorders
- Swallowing disorders
- Corticotherapy during the last week
- Allergy to lidocaine
- Urgent surgery
- Nasogastric, oro-gastric
- Ventral position
- More than 2 intubation attempts
- Continuous intravenous infusion of lidocaine intraoperatively.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ogarite Habiblead
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hicham Jabbour, MD
Saint JU
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 22, 2018
First Posted
January 3, 2019
Study Start
January 1, 2019
Primary Completion
April 1, 2019
Study Completion
October 1, 2020
Last Updated
January 15, 2019
Record last verified: 2019-01